JAZZ PHARMACEUTICALS
Failures and doubting investors have not dissuaded Glenmark Pharma's Glenn SaldanhaGlenmark has netted over $200 million in milestone and upfront payments while it has spent about $120-130 million on research.22 May, 2011, 02.06 AM IST
Load More